BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
34.24
0.87 (2.61%)
At close: May 30, 2025, 3:59 PM
33.50
-2.16%
After-hours: May 30, 2025, 05:04 PM EDT
2.61% (1D)
| Bid | 33.5 |
| Market Cap | 6.5B |
| Revenue (ttm) | 127.42M |
| Net Income (ttm) | -667.97M |
| EPS (ttm) | -3.56 |
| PE Ratio (ttm) | -9.62 |
| Forward PE | -17.1 |
| Analyst | Buy |
| Ask | 35.5 |
| Volume | 2,314,236 |
| Avg. Volume (20D) | 2,969,375 |
| Open | 33.09 |
| Previous Close | 33.37 |
| Day's Range | 32.37 - 34.73 |
| 52-Week Range | 21.62 - 39.54 |
| Beta | 1.15 |
About BBIO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BBIO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BBIO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+5.33%
BridgeBio Pharma shares are trading higher after t...
Unlock content with
Pro Subscription
1 month ago
+1.48%
BridgeBio Pharma shares are trading higher after the company reported better-than-expected Q1 financial results.
